Interscalene Block Versus Costoclavicular Block for Shoulder Surgery

July 8, 2018 updated by: Julian Aliste, University of Chile

A Randomized Comparison Between Interscalene and Costoclavicular Infraclavicular Brachial Plexus Blocks For Arthroscopic Shoulder Surgery

Interscalene brachial plexus block constitutes the analgesic criterion standard for shoulder surgery. However, it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. This randomized controlled trial (RCT) will compare ultrasound-guided interscalene block (ISB) and costoclavicular infraclavicular block (CCICB) in patients undergoing arthroscopic shoulder surgery.

The main outcome is static pain at 30 minutes after arrival in the post anesthesia care unit (PACU) as measured by a numerical rate scale (NRS) from 0 to 10. Our research hypothesis is that interscalene and costoclavicular infraclavicular blocks will result in equivalent postoperative analgesia at 30 minutes in the PACU. The equivalence margin is set at 2 points.

Study Overview

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Metropolitana
      • Santiago, Metropolitana, Chile, 8380456
        • Hospital Clinico Universidad de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing arthroscopic shoulder surgery
  • American Society of Anesthesiologists classification 1-3
  • Body mass index between 20 and 35

Exclusion Criteria:

  • Adults who are unable to give their own consent
  • Pre-existing neuropathy
  • Coagulopathy
  • Obstructive or restrictive pulmonary disease
  • Renal failure
  • Hepatic failure
  • Allergy to local anesthetics
  • Pregnancy
  • Prior surgery in the corresponding side of the neck or infraclavicular fossa
  • Chronic pain syndromes requiring opioid intake at home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Interscalene Block
Patients randomized to receive an intesrcalene block.
Injection with ultrasound guidance of 20mL of levobupivacaine 0.5% with 5 micrograms of epinephrine per mL in the interscalene groove of the brachial plexus.
Experimental: Costoclavicular Infraclavicular Block
Patients randomized to receive a costoclavicular infraclavicular block.
Ultrasound guided brachial plexus block injecting 20mL of 0.5% levobupivacaine with 5 micrograms of epinephrine per mL in between the cords of the brachial plexus at the costoclavicular infraclavicular space.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static pain at 30 minutes after arrival in the PACU
Time Frame: 30 minutes
Evaluated with a NRS from 0 to 10
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Block performance time
Time Frame: 1 hour before surgery
Time from skin disinfection until the end of local anesthetic injection
1 hour before surgery
Intraoperative opioid requirements
Time Frame: Intraoperative period
Total amount of fentanyl required during general anesthesia
Intraoperative period
Static pain at 60 minutes after arrival in the PACU
Time Frame: 60 minutes
Evaluated with a NRS from 0 to 10
60 minutes
Postoperative static pain at 2 hours
Time Frame: 2 hours
Evaluated with a NRS from 0 to 10
2 hours
Postoperative static pain at 3 hours
Time Frame: 3 hours
Evaluated with a NRS from 0 to 10
3 hours
Postoperative static pain at 6 hours
Time Frame: 6 hours
Evaluated with a NRS from 0 to 10
6 hours
Postoperative static pain at 12 hours
Time Frame: 12 hours
Evaluated with a NRS from 0 to 10
12 hours
Postoperative static pain at 24 hours
Time Frame: 24 hours
Evaluated with a NRS from 0 to 10
24 hours
Incidence of HDP at 30 minutes after interscalene or costoclavicular infraclavicular block
Time Frame: 30 minutes post injection
Ultrasound diagnosed HDP
30 minutes post injection
Incidence of HDP at 30 minutes after arrival to PACU
Time Frame: 30 minutes after arrival to the PACU
Ultrasound diagnosed HDP
30 minutes after arrival to the PACU
Sensory and Motor block score
Time Frame: 30 minutes post injection
Sensorimotor block assessed every 5 minutes until 30 minutes using a 8-point composite score
30 minutes post injection
Incidence of complete block
Time Frame: 30 minutes post injection
Percentage of blocks with a minimal sensorimotor composite score of 6 points out of a maximum of 8 points at 30 minutes post injection
30 minutes post injection
Procedural pain during blocks
Time Frame: 1 hour before surgery
Evaluated with a NRS from 0 to 10
1 hour before surgery
Onset time
Time Frame: 1 hour before surgery
Time required to reach a minimal sensorimotor composite score of 6 points out of a maximum of 8 points
1 hour before surgery
Surgical duration
Time Frame: Intraoperative period
Time between skin incision and closure
Intraoperative period
Postoperative opioid consumption
Time Frame: 24 hours after surgery
Total amount of morphine required during the first 24 hours after surgery
24 hours after surgery
Patient satisfaction
Time Frame: 24 hours after surgery
Patient satisfaction measured using a NRS 0 to 10 (0 = unsatisfied; 10 =very satisfied)
24 hours after surgery
Block- and opioid-related side effects
Time Frame: 1 week
Incidence of side effects
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2018

Primary Completion (Actual)

July 6, 2018

Study Completion (Actual)

July 6, 2018

Study Registration Dates

First Submitted

January 5, 2018

First Submitted That Met QC Criteria

January 18, 2018

First Posted (Actual)

January 26, 2018

Study Record Updates

Last Update Posted (Actual)

July 10, 2018

Last Update Submitted That Met QC Criteria

July 8, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Interscalene Block

3
Subscribe